Stockscreener 앱 받기
0.525
0.94%
-0.005
전일 마감가:
$0.53
열려 있는:
$0.54
하루 거래량:
1,933
Relative Volume:
0.05
시가총액:
$13.51M
수익:
$12.00M
순이익/손실:
$-63.23M
주가수익비율:
-0.0875
EPS:
-6
순현금흐름:
$-43.02M
1주 성능:
-2.05%
1개월 성능:
-19.23%
6개월 성능:
-73.95%
1년 성능:
-43.23%
1일 변동 폭
$0.54
$0.55
1주일 범위
$0.496
$0.568
52주 변동 폭
$0.49
$2.09
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
명칭
Accelerate Diagnostics Inc
전화
303-863-8088
주소
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
AXDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AXDX
Accelerate Diagnostics Inc
|
0.546 | 13.51M | 12.00M | -63.23M | -43.02M | -6.00 |
|
ABT
Abbott Laboratories
|
132.40 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.42 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.86 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.57 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.37 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-09 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2020-10-08 | 개시 | BTIG Research | Neutral |
| 2020-08-07 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-09-27 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-11-07 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-05-24 | 개시 | Craig Hallum | Hold |
| 2017-12-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2017-07-12 | 재개 | BTIG Research | Buy |
| 2016-03-24 | 개시 | JP Morgan | Overweight |
| 2015-12-16 | 개시 | Piper Jaffray | Overweight |
모두보기
Accelerate Diagnostics Inc 주식(AXDX)의 최신 뉴스
Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Short Interest Update - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated at StockNews.com - Defense World
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics grants CEO retention bonus - Investing.com Australia
Accelerate Diagnostics grants CEO retention bonus By Investing.com - Investing.com Canada
Accelerate Diagnostics CEO Retention Bonus Agreement - TipRanks
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Sees Significant Decrease in Short Interest - Defense World
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs - The Manila Times
Renovaro Secures High-Powered Computing from Nebul Through - GlobeNewswire
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World
Accelerate Diagnostics adds new independent directors - Investing.com Australia
Accelerate Diagnostics adds new independent directors By Investing.com - Investing.com Canada
Accelerate Diagnostics (AXDX) Appoints New Directors and Forms S - GuruFocus
Accelerate Diagnostics Appoints New Independent Directors - TipRanks
Accelerate Diagnostics board forms committee to exlore strategic alternatives - TipRanks
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - Yahoo Finance
Accelerate Diagnostics CTO sells shares worth $989 By Investing.com - Investing.com UK
Accelerate Diagnostics CTO sells shares worth $989 - Investing.com
Accelerate Diagnostics CEO Jack Phillips sells $16,472 in stock - Investing.com
Accelerate Diagnostics CEO Sells Shares to Cover Tax Obligations - TradingView
AXDX stock touches 52-week low at $0.63 amid market challenges - Investing.com India
Microbial Identification Methods Market Forecasted to Grow at 6.64% CAGR, Reaching $8.16 Billion by 2030The Insight Partners - Yahoo Finance
Automotive Diagnostics Scanner Market to Accelerate Growth with Actron, Denso, Launch Tech - newstrail.com
Accelerate Diagnostics CFO sells shares worth $4,839 By Investing.com - Investing.com South Africa
Accelerate Diagnostics CFO sells shares worth $4,839 - Investing.com
Accelerate Diagnostics (NASDAQ:AXDX) Shares Pass Below 200 Day Moving Average – What’s Next? - Defense World
AXDX stock touches 52-week low at $0.73 amid market challenges By Investing.com - Investing.com South Africa
AXDX stock touches 52-week low at $0.73 amid market challenges - Investing.com Australia
Accelerate Diagnostics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Accelerate Diagnostics (NASDAQ:AXDX) Now Covered by Analysts at StockNews.com - Defense World
Accelerate Diagnostics Reports 2024 Financial Results - TipRanks
Antimicrobial Susceptibility Testing Market Expecting Huge Demand in Upcoming Years Accelerate Diagnostics - openPR.com
Accelerate Diagnostics Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
Accelerate Diagnostics seeks FDA clearance for WAVE system By Investing.com - Investing.com Australia
Accelerate Diagnostics seeks FDA clearance for WAVE system - Investing.com India
InventHelp Inventor Develops Modified Single-Serve Coffeemaker (KXK-162) - The Malaysian Reserve
Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PR Newswire
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PR Newswire
Accelerate Diagnostics Inc. (AXDX) reports earnings - Quartz
Accelerate Diagnostics, Inc SEC 10-K Report - TradingView
Accelerate Diagnostics (AXDX) Expected to Announce Quarterly Earnings on Thursday - Defense World
Accelerate Diagnostics Inc (AXDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Accelerate Diagnostics Inc 주식 (AXDX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Phillips Jack | Chief Executive Officer |
Apr 04 '25 |
Sale |
0.65 |
25,343 |
16,473 |
191,374 |
| Mertz Larry Michael | Chief Technology Officer |
Apr 04 '25 |
Option Exercise |
0.00 |
4,298 |
0 |
86,326 |
| Mertz Larry Michael | Chief Technology Officer |
Apr 04 '25 |
Sale |
0.65 |
1,523 |
990 |
84,803 |
| Patience David | Chief Financial Officer |
Apr 01 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
71,384 |
| Patience David | Chief Financial Officer |
Apr 01 '25 |
Sale |
0.71 |
6,816 |
4,839 |
64,568 |
| Patience David | Chief Financial Officer |
Feb 26 '25 |
Option Exercise |
0.00 |
1,500 |
0 |
51,919 |
| Patience David | Chief Financial Officer |
Feb 26 '25 |
Sale |
1.09 |
535 |
583 |
51,384 |
| Phillips Jack | Chief Executive Officer |
Feb 01 '25 |
Option Exercise |
0.00 |
1,000 |
0 |
163,919 |
| Phillips Jack | Chief Executive Officer |
Feb 03 '25 |
Sale |
1.35 |
485 |
655 |
163,434 |
| PATIENCE JOHN | Director |
Dec 03 '24 |
Buy |
1.57 |
200,000 |
314,000 |
653,224 |
9.38%
0.12%
자본화:
|
볼륨(24시간):